ReachMD

Dr. Samuel Gandy recently left Thomas Jefferson University in Philadelphia to accept the position of professor of Alzheimer's disease research, professor of neurology and psychiatry, and associate director of the Mount Sinai Alzheimer's Disease Research Center in New York. He also chairs the National Medical and Scientific Advisory Council of the Alzheimer's Association.

Dr. Gandy completed his internship in internal medicine at the Columbia University College of Physicians and surgeons, and completed his residency in neurology at Cornell University Medical College. Dr. Gandy received his MD from the Medical University of South Carolina.

Dr. Samuel Gandy is an international expert in the metabolism of the substance called amyloid that clogs the brain in patients with Alzheimer's. In 1989, Dr. Gandy and his team discovered the first drugs that could lower formation of amyloid. Dr. Gandy has written more than 150 original papers, chapters and reviews on this topic. Dr. Gandy has received continuous NIH funding for his research on amyloid metabolism since 1986.